APO Research

APO RESEARCH · REPORT

Custom Assay Development

Selected research

Market Analysis & Forecast

Global Custom Assay Development Market Analysis and Forecast 2026-2032

Market perspective

The global Custom Assay Development market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Custom Assay Development is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Custom Assay Development is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Custom Assay Development is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Custom Assay Development is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Custom Assay Development include 2BScientific, PerkinElmer, Eurofins Discovery, Thermo Fisher Scientific, Creative Biolabs, PlexBio, Gyros Protein Technologies, Mission Bio and Sygnature Discovery, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Custom Assay Development, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Custom Assay Development, also provides the revenue of main regions and countries. Of the upcoming market potential for Custom Assay Development, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Custom Assay Development revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Custom Assay Development market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Custom Assay Development revenue, projected growth trends, production technology, application and end-user industry.

Custom Assay Development Segment by Company

2BScientific

PerkinElmer

Eurofins Discovery

Thermo Fisher Scientific

Creative Biolabs

PlexBio

Gyros Protein Technologies

Mission Bio

Sygnature Discovery

AssayGate

Charles River Laboratories

Promega Corporation

ProteoGenix

R&D Systems

Luminex

Eremid Genomic Services

INDIGO Biosciences

Cellomatics Biosciences

Camtech

SynVivo

Custom Assay Development Segment by Type

Assay Development

Assay Optimization

Assay Conversion

New Analyte Development

Custom Coupling

Custom Conjugation

Sample Testing

Other

Custom Assay Development Segment by Application

Medicine

Biology

Environment

Academic

Others

Custom Assay Development Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Assay Development market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom Assay Development and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Assay Development.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Custom Assay Development in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Custom Assay Development company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Custom Assay Development revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Custom Assay Development Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Assay Development Major Player Table 3. Assay Optimization Major Player Table 4. Assay Conversion Major Player Table 5. New Analyte Development Major Player Table 6. Custom Coupling Major Player Table 7. Custom Conjugation Major Player Table 8. Sample Testing Major Player Table 9. Other Major Player Table 10. Global Custom Assay Development Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 11. Medicine Major Player Table 12. Biology Major Player Table 13. Environment Major Player Table 14. Academic Major Player Table 15. Others Major Player Table 16. Custom Assay Development Industry Trends Table 17. Custom Assay Development Industry Drivers Table 18. Custom Assay Development Industry Opportunities and Challenges Table 19. Custom Assay Development Industry Restraints Table 20. Global Custom Assay Development Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 21. Global Custom Assay Development Market Size by Region (2021-2026) & (US$ Million) Table 22. Global Custom Assay Development Market Share by Region (2021-2026) Table 23. Global Custom Assay Development Market Size by Region (2027-2032) & (US$ Million) Table 24. Global Custom Assay Development Market Share by Region (2027-2032) Table 25. Global Custom Assay Development Revenue by Players (US$ Million) & (2021-2026) Table 26. Global Custom Assay Development Revenue Market Share by Players (2021-2026) Table 27. Global Custom Assay Development Key Players Ranking, 2024 VS 2025 VS 2026 Table 28. Global Custom Assay Development Key Players Headquarters & Area Served Table 29. Global Custom Assay Development Players, Product Type & Application Table 30. Global Custom Assay Development Players Establishment Date Table 31. Global Players Market Concentration Ratio (CR5 and HHI) Table 32. Global Custom Assay Development by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Custom Assay Development Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Custom Assay Development Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Custom Assay Development Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Custom Assay Development Revenue Market Share by Type (2021-2026) Table 37. Global Custom Assay Development Revenue Market Share by Type (2027-2032) Table 38. Global Custom Assay Development Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Custom Assay Development Revenue by Application (2021-2026) & (US$ Million) Table 40. Global Custom Assay Development Revenue by Application (2027-2032) & (US$ Million) Table 41. Global Custom Assay Development Revenue Market Share by Application (2021-2026) Table 42. Global Custom Assay Development Revenue Market Share by Application (2027-2032) Table 43. 2BScientific Company Information Table 44. 2BScientific Business Overview Table 45. 2BScientific Custom Assay Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. 2BScientific Custom Assay Development Product Portfolio Table 47. 2BScientific Recent Development Table 48. PerkinElmer Company Information Table 49. PerkinElmer Business Overview Table 50. PerkinElmer Custom Assay Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. PerkinElmer Custom Assay Development Product Portfolio Table 52. PerkinElmer Recent Development Table 53. Eurofins Discovery Company Information Table 54. Eurofins Discovery Business Overview Table 55. Eurofins Discovery Custom Assay Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Eurofins Discovery Custom Assay Development Product Portfolio Table 57. Eurofins Discovery Recent Development Table 58. Thermo Fisher Scientific Company Information Table 59. Thermo Fisher Scientific Business Overview Table 60. Thermo Fisher Scientific Custom Assay Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Thermo Fisher Scientific Custom Assay Development Product Portfolio Table 62. Thermo Fisher Scientific Recent Development Table 63. Creative Biolabs Company Information Table 64. Creative Biolabs Business Overview Table 65. Creative Biolabs Custom Assay Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Creative Biolabs Custom Assay Development Product Portfolio Table 67. Creative Biolabs Recent Development Table 68. PlexBio Company Information Table 69. PlexBio Business Overview Table 70. PlexBio Custom Assay Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. PlexBio Custom Assay Development Product Portfolio Table 72. PlexBio Recent Development Table 73. Gyros Protein Technologies Company Information Table 74. Gyros Protein Technologies Business Overview Table 75. Gyros Protein Technologies Custom Assay Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Gyros Protein Technologies Custom Assay Development Product Portfolio Table 77. Gyros Protein Technologies Recent Development Table 78. Mission Bio Company Information Table 79. Mission Bio Business Overview Table 80. Mission Bio Custom Assay Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Mission Bio Custom Assay Development Product Portfolio Table 82. Mission Bio Recent Development Table 83. Sygnature Discovery Company Information Table 84. Sygnature Discovery Business Overview Table 85. Sygnature Discovery Custom Assay Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Sygnature Discovery Custom Assay Development Product Portfolio Table 87. Sygnature Discovery Recent Development Table 88. AssayGate Company Information Table 89. AssayGate Business Overview Table 90. AssayGate Custom Assay Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. AssayGate Custom Assay Development Product Portfolio Table 92. AssayGate Recent Development Table 93. Charles River Laboratories Company Information Table 94. Charles River Laboratories Business Overview Table 95. Charles River Laboratories Custom Assay Development Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Charles River Laboratories Custom Assay Development Product Portfolio Table 97. Charles River Laboratories Recent Development Table 98. Promega Corporation Company Information Table 99. Promega Corporation Business Overview Table 100. Promega Corporation Custom Assay Development Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Promega Corporation Custom Assay Development Product Portfolio Table 102. Promega Corporation Recent Development Table 103. ProteoGenix Company Information Table 104. ProteoGenix Business Overview Table 105. ProteoGenix Custom Assay Development Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. ProteoGenix Custom Assay Development Product Portfolio Table 107. ProteoGenix Recent Development Table 108. R&D Systems Company Information Table 109. R&D Systems Business Overview Table 110. R&D Systems Custom Assay Development Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. R&D Systems Custom Assay Development Product Portfolio Table 112. R&D Systems Recent Development Table 113. Luminex Company Information Table 114. Luminex Business Overview Table 115. Luminex Custom Assay Development Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Luminex Custom Assay Development Product Portfolio Table 117. Luminex Recent Development Table 118. Eremid Genomic Services Company Information Table 119. Eremid Genomic Services Business Overview Table 120. Eremid Genomic Services Custom Assay Development Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Eremid Genomic Services Custom Assay Development Product Portfolio Table 122. Eremid Genomic Services Recent Development Table 123. INDIGO Biosciences Company Information Table 124. INDIGO Biosciences Business Overview Table 125. INDIGO Biosciences Custom Assay Development Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. INDIGO Biosciences Custom Assay Development Product Portfolio Table 127. INDIGO Biosciences Recent Development Table 128. Cellomatics Biosciences Company Information Table 129. Cellomatics Biosciences Business Overview Table 130. Cellomatics Biosciences Custom Assay Development Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Cellomatics Biosciences Custom Assay Development Product Portfolio Table 132. Cellomatics Biosciences Recent Development Table 133. Camtech Company Information Table 134. Camtech Business Overview Table 135. Camtech Custom Assay Development Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Camtech Custom Assay Development Product Portfolio Table 137. Camtech Recent Development Table 138. SynVivo Company Information Table 139. SynVivo Business Overview Table 140. SynVivo Custom Assay Development Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. SynVivo Custom Assay Development Product Portfolio Table 142. SynVivo Recent Development Table 143. North America Custom Assay Development Revenue by Type (2021-2026) & (US$ Million) Table 144. North America Custom Assay Development Revenue by Type (2027-2032) & (US$ Million) Table 145. North America Custom Assay Development Revenue by Application (2021-2026) & (US$ Million) Table 146. North America Custom Assay Development Revenue by Application (2027-2032) & (US$ Million) Table 147. North America Custom Assay Development Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. North America Custom Assay Development Revenue by Country (2021-2026) & (US$ Million) Table 149. North America Custom Assay Development Revenue by Country (US$ Million) & (2027-2032) Table 150. Europe Custom Assay Development Revenue by Type (2021-2026) & (US$ Million) Table 151. Europe Custom Assay Development Revenue by Type (2027-2032) & (US$ Million) Table 152. Europe Custom Assay Development Revenue by Application (2021-2026) & (US$ Million) Table 153. Europe Custom Assay Development Revenue by Application (2027-2032) & (US$ Million) Table 154. Europe Custom Assay Development Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Europe Custom Assay Development Revenue by Country (2021-2026) & (US$ Million) Table 156. Europe Custom Assay Development Revenue by Country (US$ Million) & (2027-2032) Table 157. China Custom Assay Development Revenue by Type (2021-2026) & (US$ Million) Table 158. China Custom Assay Development Revenue by Type (2027-2032) & (US$ Million) Table 159. China Custom Assay Development Revenue by Application (2021-2026) & (US$ Million) Table 160. China Custom Assay Development Revenue by Application (2027-2032) & (US$ Million) Table 161. Asia Custom Assay Development Revenue by Type (2021-2026) & (US$ Million) Table 162. Asia Custom Assay Development Revenue by Type (2027-2032) & (US$ Million) Table 163. Asia Custom Assay Development Revenue by Application (2021-2026) & (US$ Million) Table 164. Asia Custom Assay Development Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia Custom Assay Development Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 166. Asia Custom Assay Development Revenue by Region (US$ Million) & (2021-2026) Table 167. Asia Custom Assay Development Revenue by Region (US$ Million) & (2027-2032) Table 168. SAMEA Custom Assay Development Revenue by Type (2021-2026) & (US$ Million) Table 169. SAMEA Custom Assay Development Revenue by Type (2027-2032) & (US$ Million) Table 170. SAMEA Custom Assay Development Revenue by Application (2021-2026) & (US$ Million) Table 171. SAMEA Custom Assay Development Revenue by Application (2027-2032) & (US$ Million) Table 172. SAMEA Custom Assay Development Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. SAMEA Custom Assay Development Revenue by Country (2021-2026) & (US$ Million) Table 174. SAMEA Custom Assay Development Revenue by Country (US$ Million) & (2027-2032) Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Custom Assay Development Image Figure 2. Global Custom Assay Development Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Custom Assay Development Market Size Share 2021 VS 2025 VS 2032 Figure 4. Assay Development Image Figure 5. Assay Optimization Image Figure 6. Assay Conversion Image Figure 7. New Analyte Development Image Figure 8. Custom Coupling Image Figure 9. Custom Conjugation Image Figure 10. Sample Testing Image Figure 11. Other Image Figure 12. Global Custom Assay Development Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Custom Assay Development Market Size Share 2021 VS 2025 VS 2032 Figure 14. Medicine Image Figure 15. Biology Image Figure 16. Environment Image Figure 17. Academic Image Figure 18. Others Image Figure 19. Global Custom Assay Development Market Size (US$ Million) & (2021-2032) Figure 20. Global Custom Assay Development Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 21. Global Custom Assay Development Market Share by Region: 2021 VS 2025 VS 2032 Figure 22. Global Custom Assay Development Players Revenue Share Top 10 and Top 5 in 2025 Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global Custom Assay Development Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Custom Assay Development Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Custom Assay Development Revenue Market Share by Type (2021-2032) Figure 27. Global Custom Assay Development Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Custom Assay Development Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 29. Global Custom Assay Development Revenue Market Share by Application (2021-2032) Figure 30. North America Custom Assay Development Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. North America Custom Assay Development Revenue Share by Type (2021-2032) Figure 32. North America Custom Assay Development Revenue Share by Application (2021-2032) Figure 33. North America Custom Assay Development Revenue Share by Country (2021-2032) Figure 34. United States Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Canada Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Mexico Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Europe Custom Assay Development Revenue YoY Growth (2021-2032) & (US$ Million) Figure 38. Europe Custom Assay Development Revenue Share by Type (2021-2032) Figure 39. Europe Custom Assay Development Revenue Share by Application (2021-2032) Figure 40. Europe Custom Assay Development Revenue Share by Country (2021-2032) Figure 41. Germany Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. France Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. U.K. Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Italy Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Spain Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Russia Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. Netherlands Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. Nordic Countries Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. China Custom Assay Development Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. China Custom Assay Development Revenue Share by Type (2021-2032) Figure 51. China Custom Assay Development Revenue Share by Application (2021-2032) Figure 52. Asia Custom Assay Development Revenue YoY Growth (2021-2032) & (US$ Million) Figure 53. Asia Custom Assay Development Revenue Share by Type (2021-2032) Figure 54. Asia Custom Assay Development Revenue Share by Application (2021-2032) Figure 55. Asia Custom Assay Development Revenue Share by Region (2021-2032) Figure 56. Japan Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. South Korea Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. India Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Australia Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Taiwan Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Southeast Asia Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. SAMEA Custom Assay Development Revenue YoY Growth (2021-2032) & (US$ Million) Figure 63. SAMEA Custom Assay Development Revenue Share by Type (2021-2032) Figure 64. SAMEA Custom Assay Development Revenue Share by Application (2021-2032) Figure 65. SAMEA Custom Assay Development Revenue Share by Country (2021-2032) Figure 66. Brazil Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Argentina Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Chile Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Colombia Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Peru Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Saudi Arabia Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Israel Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. UAE Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Turkey Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Iran Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 76. Egypt Custom Assay Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Assay Development
  • Assay Optimization
  • Assay Conversion
  • New Analyte Development
  • Custom Coupling
  • Custom Conjugation
  • Sample Testing
  • Other
Applications
  • Medicine
  • Biology
  • Environment
  • Academic
  • Others
Companies covered
  • 2BScientific
  • PerkinElmer
  • Eurofins Discovery
  • Thermo Fisher Scientific
  • Creative Biolabs
  • PlexBio
  • Gyros Protein Technologies
  • Mission Bio
  • Sygnature Discovery
  • AssayGate
  • Charles River Laboratories
  • Promega Corporation
  • ProteoGenix
  • R&D Systems
  • Luminex
  • Eremid Genomic Services
  • INDIGO Biosciences
  • Cellomatics Biosciences
  • Camtech
  • SynVivo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Custom Assay Development Market by Type
  3. 1.2.1 Global Custom Assay Development Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Assay Development
  5. 1.2.3 Assay Optimization
  6. 1.2.4 Assay Conversion
  7. 1.2.5 New Analyte Development
  8. 1.2.6 Custom Coupling
  9. 1.2.7 Custom Conjugation
  10. 1.2.8 Sample Testing
  11. 1.2.9 Other
  12. 1.3 Custom Assay Development Market by Application
  13. 1.3.1 Global Custom Assay Development Market Size by Application, 2021 VS 2025 VS 2032
  14. 1.3.2 Medicine
  15. 1.3.3 Biology
  16. 1.3.4 Environment
  17. 1.3.5 Academic
  18. 1.3.6 Others
  19. 1.4 Assumptions and Limitations
  20. 1.5 Study Goals and Objectives
2 Custom Assay Development Market Dynamics
  1. 2.1 Custom Assay Development Industry Trends
  2. 2.2 Custom Assay Development Industry Drivers
  3. 2.3 Custom Assay Development Industry Opportunities and Challenges
  4. 2.4 Custom Assay Development Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Custom Assay Development Market Perspective (2021-2032)
  2. 3.2 Global Custom Assay Development Growth Trends by Region
  3. 3.2.1 Global Custom Assay Development Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Custom Assay Development Market Size by Region (2021-2026)
  5. 3.2.3 Global Custom Assay Development Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Custom Assay Development Revenue by Players
  2. 4.1.1 Global Custom Assay Development Revenue by Players (2021-2026)
  3. 4.1.2 Global Custom Assay Development Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Custom Assay Development Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Custom Assay Development Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Custom Assay Development Key Players Headquarters & Area Served
  7. 4.4 Global Custom Assay Development Players, Product Type & Application
  8. 4.5 Global Custom Assay Development Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Custom Assay Development Market CR5 and HHI
  11. 4.6.3 2025 Custom Assay Development Tier 1, Tier 2, and Tier 3
5 Custom Assay Development Market Size by Type
  1. 5.1 Global Custom Assay Development Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Custom Assay Development Revenue by Type (2021-2032)
  3. 5.3 Global Custom Assay Development Revenue Market Share by Type (2021-2032)
6 Custom Assay Development Market Size by Application
  1. 6.1 Global Custom Assay Development Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Custom Assay Development Revenue by Application (2021-2032)
  3. 6.3 Global Custom Assay Development Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 2BScientific
  2. 7.1.1 2BScientific Company Information
  3. 7.1.2 2BScientific Business Overview
  4. 7.1.3 2BScientific Custom Assay Development Revenue and Gross Margin (2021-2026)
  5. 7.1.4 2BScientific Custom Assay Development Product Portfolio
  6. 7.1.5 2BScientific Recent Developments
  7. 7.2 PerkinElmer
  8. 7.2.1 PerkinElmer Company Information
  9. 7.2.2 PerkinElmer Business Overview
  10. 7.2.3 PerkinElmer Custom Assay Development Revenue and Gross Margin (2021-2026)
  11. 7.2.4 PerkinElmer Custom Assay Development Product Portfolio
  12. 7.2.5 PerkinElmer Recent Developments
  13. 7.3 Eurofins Discovery
  14. 7.3.1 Eurofins Discovery Company Information
  15. 7.3.2 Eurofins Discovery Business Overview
  16. 7.3.3 Eurofins Discovery Custom Assay Development Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Eurofins Discovery Custom Assay Development Product Portfolio
  18. 7.3.5 Eurofins Discovery Recent Developments
  19. 7.4 Thermo Fisher Scientific
  20. 7.4.1 Thermo Fisher Scientific Company Information
  21. 7.4.2 Thermo Fisher Scientific Business Overview
  22. 7.4.3 Thermo Fisher Scientific Custom Assay Development Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Thermo Fisher Scientific Custom Assay Development Product Portfolio
  24. 7.4.5 Thermo Fisher Scientific Recent Developments
  25. 7.5 Creative Biolabs
  26. 7.5.1 Creative Biolabs Company Information
  27. 7.5.2 Creative Biolabs Business Overview
  28. 7.5.3 Creative Biolabs Custom Assay Development Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Creative Biolabs Custom Assay Development Product Portfolio
  30. 7.5.5 Creative Biolabs Recent Developments
  31. 7.6 PlexBio
  32. 7.6.1 PlexBio Company Information
  33. 7.6.2 PlexBio Business Overview
  34. 7.6.3 PlexBio Custom Assay Development Revenue and Gross Margin (2021-2026)
  35. 7.6.4 PlexBio Custom Assay Development Product Portfolio
  36. 7.6.5 PlexBio Recent Developments
  37. 7.7 Gyros Protein Technologies
  38. 7.7.1 Gyros Protein Technologies Company Information
  39. 7.7.2 Gyros Protein Technologies Business Overview
  40. 7.7.3 Gyros Protein Technologies Custom Assay Development Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Gyros Protein Technologies Custom Assay Development Product Portfolio
  42. 7.7.5 Gyros Protein Technologies Recent Developments
  43. 7.8 Mission Bio
  44. 7.8.1 Mission Bio Company Information
  45. 7.8.2 Mission Bio Business Overview
  46. 7.8.3 Mission Bio Custom Assay Development Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Mission Bio Custom Assay Development Product Portfolio
  48. 7.8.5 Mission Bio Recent Developments
  49. 7.9 Sygnature Discovery
  50. 7.9.1 Sygnature Discovery Company Information
  51. 7.9.2 Sygnature Discovery Business Overview
  52. 7.9.3 Sygnature Discovery Custom Assay Development Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Sygnature Discovery Custom Assay Development Product Portfolio
  54. 7.9.5 Sygnature Discovery Recent Developments
  55. 7.10 AssayGate
  56. 7.10.1 AssayGate Company Information
  57. 7.10.2 AssayGate Business Overview
  58. 7.10.3 AssayGate Custom Assay Development Revenue and Gross Margin (2021-2026)
  59. 7.10.4 AssayGate Custom Assay Development Product Portfolio
  60. 7.10.5 AssayGate Recent Developments
  61. 7.11 Charles River Laboratories
  62. 7.11.1 Charles River Laboratories Company Information
  63. 7.11.2 Charles River Laboratories Business Overview
  64. 7.11.3 Charles River Laboratories Custom Assay Development Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Charles River Laboratories Custom Assay Development Product Portfolio
  66. 7.11.5 Charles River Laboratories Recent Developments
  67. 7.12 Promega Corporation
  68. 7.12.1 Promega Corporation Company Information
  69. 7.12.2 Promega Corporation Business Overview
  70. 7.12.3 Promega Corporation Custom Assay Development Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Promega Corporation Custom Assay Development Product Portfolio
  72. 7.12.5 Promega Corporation Recent Developments
  73. 7.13 ProteoGenix
  74. 7.13.1 ProteoGenix Company Information
  75. 7.13.2 ProteoGenix Business Overview
  76. 7.13.3 ProteoGenix Custom Assay Development Revenue and Gross Margin (2021-2026)
  77. 7.13.4 ProteoGenix Custom Assay Development Product Portfolio
  78. 7.13.5 ProteoGenix Recent Developments
  79. 7.14 R&D Systems
  80. 7.14.1 R&D Systems Company Information
  81. 7.14.2 R&D Systems Business Overview
  82. 7.14.3 R&D Systems Custom Assay Development Revenue and Gross Margin (2021-2026)
  83. 7.14.4 R&D Systems Custom Assay Development Product Portfolio
  84. 7.14.5 R&D Systems Recent Developments
  85. 7.15 Luminex
  86. 7.15.1 Luminex Company Information
  87. 7.15.2 Luminex Business Overview
  88. 7.15.3 Luminex Custom Assay Development Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Luminex Custom Assay Development Product Portfolio
  90. 7.15.5 Luminex Recent Developments
  91. 7.16 Eremid Genomic Services
  92. 7.16.1 Eremid Genomic Services Company Information
  93. 7.16.2 Eremid Genomic Services Business Overview
  94. 7.16.3 Eremid Genomic Services Custom Assay Development Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Eremid Genomic Services Custom Assay Development Product Portfolio
  96. 7.16.5 Eremid Genomic Services Recent Developments
  97. 7.17 INDIGO Biosciences
  98. 7.17.1 INDIGO Biosciences Company Information
  99. 7.17.2 INDIGO Biosciences Business Overview
  100. 7.17.3 INDIGO Biosciences Custom Assay Development Revenue and Gross Margin (2021-2026)
  101. 7.17.4 INDIGO Biosciences Custom Assay Development Product Portfolio
  102. 7.17.5 INDIGO Biosciences Recent Developments
  103. 7.18 Cellomatics Biosciences
  104. 7.18.1 Cellomatics Biosciences Company Information
  105. 7.18.2 Cellomatics Biosciences Business Overview
  106. 7.18.3 Cellomatics Biosciences Custom Assay Development Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Cellomatics Biosciences Custom Assay Development Product Portfolio
  108. 7.18.5 Cellomatics Biosciences Recent Developments
  109. 7.19 Camtech
  110. 7.19.1 Camtech Company Information
  111. 7.19.2 Camtech Business Overview
  112. 7.19.3 Camtech Custom Assay Development Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Camtech Custom Assay Development Product Portfolio
  114. 7.19.5 Camtech Recent Developments
  115. 7.20 SynVivo
  116. 7.20.1 SynVivo Company Information
  117. 7.20.2 SynVivo Business Overview
  118. 7.20.3 SynVivo Custom Assay Development Revenue and Gross Margin (2021-2026)
  119. 7.20.4 SynVivo Custom Assay Development Product Portfolio
  120. 7.20.5 SynVivo Recent Developments
8 North America
  1. 8.1 North America Custom Assay Development Revenue (2021-2032)
  2. 8.2 North America Custom Assay Development Revenue by Type (2021-2032)
  3. 8.2.1 North America Custom Assay Development Revenue by Type (2021-2026)
  4. 8.2.2 North America Custom Assay Development Revenue by Type (2027-2032)
  5. 8.3 North America Custom Assay Development Revenue Share by Type (2021-2032)
  6. 8.4 North America Custom Assay Development Revenue by Application (2021-2032)
  7. 8.4.1 North America Custom Assay Development Revenue by Application (2021-2026)
  8. 8.4.2 North America Custom Assay Development Revenue by Application (2027-2032)
  9. 8.5 North America Custom Assay Development Revenue Share by Application (2021-2032)
  10. 8.6 North America Custom Assay Development Revenue by Country
  11. 8.6.1 North America Custom Assay Development Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Custom Assay Development Revenue by Country (2021-2026)
  13. 8.6.3 North America Custom Assay Development Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Custom Assay Development Revenue (2021-2032)
  2. 9.2 Europe Custom Assay Development Revenue by Type (2021-2032)
  3. 9.2.1 Europe Custom Assay Development Revenue by Type (2021-2026)
  4. 9.2.2 Europe Custom Assay Development Revenue by Type (2027-2032)
  5. 9.3 Europe Custom Assay Development Revenue Share by Type (2021-2032)
  6. 9.4 Europe Custom Assay Development Revenue by Application (2021-2032)
  7. 9.4.1 Europe Custom Assay Development Revenue by Application (2021-2026)
  8. 9.4.2 Europe Custom Assay Development Revenue by Application (2027-2032)
  9. 9.5 Europe Custom Assay Development Revenue Share by Application (2021-2032)
  10. 9.6 Europe Custom Assay Development Revenue by Country
  11. 9.6.1 Europe Custom Assay Development Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Custom Assay Development Revenue by Country (2021-2026)
  13. 9.6.3 Europe Custom Assay Development Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Custom Assay Development Revenue (2021-2032)
  2. 10.2 China Custom Assay Development Revenue by Type (2021-2032)
  3. 10.2.1 China Custom Assay Development Revenue by Type (2021-2026)
  4. 10.2.2 China Custom Assay Development Revenue by Type (2027-2032)
  5. 10.3 China Custom Assay Development Revenue Share by Type (2021-2032)
  6. 10.4 China Custom Assay Development Revenue by Application (2021-2032)
  7. 10.4.1 China Custom Assay Development Revenue by Application (2021-2026)
  8. 10.4.2 China Custom Assay Development Revenue by Application (2027-2032)
  9. 10.5 China Custom Assay Development Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Custom Assay Development Revenue (2021-2032)
  2. 11.2 Asia Custom Assay Development Revenue by Type (2021-2032)
  3. 11.2.1 Asia Custom Assay Development Revenue by Type (2021-2026)
  4. 11.2.2 Asia Custom Assay Development Revenue by Type (2027-2032)
  5. 11.3 Asia Custom Assay Development Revenue Share by Type (2021-2032)
  6. 11.4 Asia Custom Assay Development Revenue by Application (2021-2032)
  7. 11.4.1 Asia Custom Assay Development Revenue by Application (2021-2026)
  8. 11.4.2 Asia Custom Assay Development Revenue by Application (2027-2032)
  9. 11.5 Asia Custom Assay Development Revenue Share by Application (2021-2032)
  10. 11.6 Asia Custom Assay Development Revenue by Country
  11. 11.6.1 Asia Custom Assay Development Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Custom Assay Development Revenue by Country (2021-2026)
  13. 11.6.3 Asia Custom Assay Development Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Custom Assay Development Revenue (2021-2032)
  2. 12.2 SAMEA Custom Assay Development Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Custom Assay Development Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Custom Assay Development Revenue by Type (2027-2032)
  5. 12.3 SAMEA Custom Assay Development Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Custom Assay Development Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Custom Assay Development Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Custom Assay Development Revenue by Application (2027-2032)
  9. 12.5 SAMEA Custom Assay Development Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Custom Assay Development Revenue by Country
  11. 12.6.1 SAMEA Custom Assay Development Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Custom Assay Development Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Custom Assay Development Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research